Updating results

499 results for Stroke Sort: Relevance | Date

Stroke rehabilitation in adults (CG162)

This guideline covers stroke rehabilitation for adults and young people aged 16 and over who have had a stroke with continuing impairment, activity limitation or participation restriction. It aims to improve rehabilitation for people who have had a stroke by specifying how stroke units and multidisciplinary stroke teams should be organised. It makes detailed recommendations on assessments and interventions for the functional difficulties caused by stroke.

Clinical guideline Published June 2013

Stroke and transient ischaemic attack

All NICE products on Stroke and transient ischaemic attack. Includes any guidance, advice, NICE Pathways and quality standards.

Stroke

Everything NICE has said on preventing, diagnosing and managing stroke and transient ischaemic attack (TIA) in people over 16 in an interactive flowchart

NICE Pathway Published May 2011 Last updated February 2019

Stroke in adults (QS2)

This quality standard covers diagnosing and managing stroke in adults (over 16). It includes diagnosis, initial management, acute-phase care, rehabilitation and long-term support for people with stroke. It describes high-quality care in priority areas for improvement.

Quality standard Published June 2010 Last updated April 2016

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (CG68)

This guideline covers interventions in the acute stage of a stroke or transient ischaemic attack (TIA). It offers the best clinical advice on the diagnosis and acute management of stroke and TIA in the 48 hours after onset of symptoms, although some interventions of up to 2 weeks are covered as well.

Clinical guideline Published July 2008 Last updated March 2017

Alteplase for treating acute ischaemic stroke (TA264)

Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke (AIS)

Technology appraisal guidance Published September 2012

Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (TA249)

Evidence-based recommendations on dabigatran etexilate (Pradaxa) for preventing stroke and systemic embolism in atrial fibrillation (AF)

Technology appraisal guidance Published March 2012

Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)

Evidence-based recommendations on rivaroxaban (Xarelto) for preventing stroke and systemic embolism in atrial fibrillation (AF)

Technology appraisal guidance Published May 2012

Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (TA275)

Evidence-based recommendations on apixaban (Eliquis) for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (AF)

Technology appraisal guidance Published February 2013

Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA355)

Evidence-based recommendations on edoxaban (Lixiana) for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (AF)

Technology appraisal guidance Published September 2015

Mechanical clot retrieval for treating acute ischaemic stroke (IPG548)

Evidence-based recommendations on mechanical blood clot retrieval for treating acute ischaemic stroke

Interventional procedures guidance Published February 2016

Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting (IPG561)

Evidence-based recommendations on transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting

Interventional procedures guidance Published June 2016

MIB165: Cerebrotech Visor for detecting stroke

Advice on the use of Cerebrotech Visor for detecting stroke to aid local decision-making

Medtech innovation briefing Published December 2018

MIB175: IQoro for stroke-related dysphagia

Advice on the use of IQoro for stroke-related dysphagia to aid local decision making

Medtech innovation briefing Published March 2019

MIB153: Mechanical thrombectomy devices for acute ischaemic stroke

Advice on the use of mechanical thrombectomy devices for acute ischaemic stroke

Medtech innovation briefing Published July 2018

Atrial fibrillation: management (CG180)

This guideline covers diagnosing and managing atrial fibrillation in adults. It aims to ensure that people receive the best management to help prevent harmful complications, in particular stroke and bleeding.

Clinical guideline Published June 2014 Last updated August 2014

MIB141: Reveal LINQ insertable cardiac monitor to detect atrial fibrillation after cryptogenic stroke

Advice on the use of Reveal LINQ insertable cardiac monitor (ICM) to detect atrial fibrillation (AF) after cryptogenic stroke to aid local decision-making

Medtech innovation briefing Published February 2018

Dabigatran etexilate for the secondary prevention of stroke after an embolic stroke of undetermined source (ID1417)

Proposed [GID-TA10426] Expected publication date: TBC

Technology appraisal guidance Proposed

Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)

Evidence-based recommendations on ticagrelor (Brilique) for preventing atherothrombotic events such as heart attacks or stroke after myocardial infarction (MI)

Technology appraisal guidance Published December 2016

Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism (IPG349)

Evidence-based recommendations on percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation to prevent stroke

Interventional procedures guidance Published June 2010

Spasticity (after stroke) - botulinum toxin type A [ID768]

In development [GID-TAG499] Expected publication date: TBC

Technology appraisal guidance In development

BMI: preventing ill health and premature death in black, Asian and other minority ethnic groups (PH46)

This guideline covers the link between body mass index (BMI) and waist circumference and the risk of disease among adults from black, Asian and other minority ethnic groups in the UK. The aim was to determine whether lower cut-off points should be used for these groups as a trigger for lifestyle interventions to prevent conditions such as diabetes, myocardial infarction or stroke.

Public health guideline Published July 2013

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (update)

In development [GID-NG10071] Expected publication date: 01 May 2019

NICE guideline In development

Mechanical thrombectomy for large vessel occlusion stroke: improving clinical outcomes and reducing cost

Outcomes for patients presenting with severe stroke because of large vessel occlusion have not improved much over recent years....

QP Case Study Published March 2016 Last updated 

Cardiovascular disease: risk assessment and reduction, including lipid modification (CG181)

This guideline covers the assessment and care of adults who are at risk of or who have cardiovascular disease (CVD), such as heart disease and stroke. It aims to help healthcare professionals identify people who are at risk of cardiovascular problems including people with type 1 or type 2 diabetes, or chronic kidney disease. It describes the lifestyle changes people can make and how statins can be used to reduce their risk.

Clinical guideline Published July 2014 Last updated September 2016

Weight management: lifestyle services for overweight or obese adults (PH53)

This guideline covers multi-component lifestyle weight management services including programmes, courses, clubs or groups provided by the public, private and voluntary sector. The aim is to help people lose weight and become more physically active to reduce the risk of diseases associated with obesity. This includes coronary heart disease, stroke, type 2 diabetes and various cancers.

Public health guideline Published May 2014

The proportion of people who have had an acute stroke who receive thrombolysis for stroke

proportion of people who have had an acute stroke who receive thrombolysis for stroke Subject(s): Stroke and...

CCG indicator Published June 2016

The proportion of people who had a stroke that are supported by a stroke skilled early supported discharge (ESD) team

people who had a stroke that are supported by a stroke skilled early supported discharge (ESD) team Subject(s):...

CCG indicator Published June 2016

The proportion of patients who have had an acute stroke who spend 90% or more of their stay on a stroke unit

patients who have had an acute stroke who spend 90% or more of their stay on a stroke unit Subject(s): Stroke...

CCG indicator Published June 2016

Atrial fibrillation

Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart

NICE Pathway Published June 2014 Last updated November 2018

Atrial fibrillation (QS93)

This quality standard covers identifying and managing atrial fibrillation (including paroxysmal, persistent and permanent atrial fibrillation, and atrial flutter) in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.

Quality standard Published July 2015 Last updated February 2018

Structural heart defects

Everything NICE has said on structural heart defects in an interactive flowchart

NICE Pathway Published November 2013 Last updated August 2018

The proportion of people who have had or are having a stroke who are admitted to an acute stroke unit within 4 hours of arrival to hospital

are having a stroke who are admitted to an acute stroke unit within 4 hours of arrival to hospital Subject(s):...

CCG indicator Published June 2016

Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89)

This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots) and deep vein thrombosis (DVT) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.

NICE guideline Published March 2018

Mortality rates within 30 days of hospital admission for stroke

Mortality rates within 30 days of hospital admission for stroke Subject(s): Stroke and ischaemic attack

CCG indicator Published June 2016

Hypertension in adults: diagnosis and management (CG127)

This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively. It also aims to reduce unnecessary treatment by improving the way blood pressure is measured.

Clinical guideline Published August 2011 Last updated November 2016

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (TA210)

Evidence-based recommendations on clopidogrel (Plavix) and modified-release dipyridamole (Persantin/Asasantin Retard) for preventing occlusive vascular events

Technology appraisal guidance Published December 2010

Admission rates due to stroke in people with diabetes

Admission rates due to stroke in people with diabetes Subject(s): Diabetes Date of publication: 01 August 2016

CCG indicator Published July 2016

Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173)

This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participation in all aspects of daily living. The guideline sets out how drug treatments for neuropathic pain differ from traditional pain management.

Clinical guideline Published November 2013 Last updated April 2018

The percentage of patients with diabetes and a history of CVD (excluding haemorrhagic stroke) who are currently treated with a statin

of patients with diabetes and a history of CVD (excluding haemorrhagic stroke) who are currently treated with a statin Subject(s):

QOF indicator Published October 2018

Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (TA317)

Evidence-based recommendations on prasugrel (Efient) with percutaneous coronary intervention (PCI) for treating acute coronary syndrome (ACS)

Technology appraisal guidance Published July 2014

Dronedarone for the treatment of non-permanent atrial fibrillation (TA197)

Evidence-based recommendations on dronedarone (Multaq) for treating non-permanent atrial fibrillation (AF)

Technology appraisal guidance Published August 2010 Last updated December 2012

Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction (TA52)

Evidence-based recommendations on streptokinase (Streptase), alteplase (Actilyse), reteplase (Rapilysin) and tenecteplase (Metalyse) for early thrombolysis in

Technology appraisal guidance Published October 2002

Physical activity: exercise referral schemes (PH54)

This guideline covers exercise referral schemes for people aged 19 and older, in particular, those who are inactive or sedentary. The aim is to encourage people to be physically active.

Public health guideline Published September 2014

Proportion of people with stroke who receive joint health and social care plans on discharge from hospital

of people with stroke who receive joint health and social care plans on discharge from hospital Subject(s): Stroke and...

CCG indicator Published June 2016